Heart bypass patients may benefit from common arthritis drug
NCT ID NCT06802926
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether taking a low dose of colchicine (a medicine used for gout) every day for a year can prevent the new blood vessels created during heart bypass surgery from failing. About 100 adults who recently had bypass surgery will take colchicine or no extra treatment. The goal is to see if the drug keeps grafts open and reduces heart problems.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CABG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ruijin Hospital Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a decades-old arthritis drug protect dialysis patients' hearts and veins?
- Could skipping the breathing tube speed heart surgery recovery?
- Timing is everything: could physiotherapy minutes after extubation prevent lung complications?
- Pre-surgery exercise program may help high-risk heart patients leave the hospital sooner
- Which graft works best for Second-Time ACL surgery?
- Heart surgery showdown: which solution saves more heart muscle?